A Phase 3 Randomized, Open-Label, Multicenter Study Comparing Zanubrutinib (BGB-3111) plus Rituximab Versus Bendamustine plus Rituximab in Patients with Previously Untreated Mantle Cell Lymphoma Who Are Ineligible for Stem Cell Transplantation

Project: Research

Project Details

StatusFinished
Effective start/end date25/02/20 → 24/02/25

Keywords

  • clinical trial
  • phase 3 study
  • treatment efficacy
  • Lymphoma